Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842621 · ClinicalTrials.gov registry record
Long Term Effects of Erythrocyte Lysis
A clinical trial of Sickle Cell Disease and Hemolytic Anemia, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 390
- Enrollment target
- 1
- Study location
NCT00842621 is a study of Sickle Cell Disease and Hemolytic Anemia that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 390 participants, above the 291-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (34% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00842621, a study of Sickle Cell Disease and Hemolytic Anemia, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 390 participants
- Enrollment target
- 1
- Study location
Study Summary
In this prospective observational trial, participants with chronic hemolysis will be assessed with echocardiogram for elevated tricuspid jet velocity and other evidence of pulmonary hypertension. Participants will have laboratory studies evaluating: severity of hemolysis, splenic function, inflammation, endothelial dysfunction, and hypercoagulability. There will be 3 main categories of participants enrolled in this study: (1) pediatric participants with severe sickle cell disease (SCD) (HbSS, HbS/β° thalassemia ) who are not receiving treatment (e.g., hydroxyurea or chronic transfusions); (2) pediatric participants with other forms of SCD or severe SCD (HbSS, HbS/β° thalassemia) patients being treated with hydroxyurea or chronic transfusions; and (3) pediatric and adult participants with other non-sickling hematological disorders.
Conditions Studied
Interventions
- PROCEDURE Clinical Evaluations
- OTHER Laboratory Studies
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 390 participants |
| Start Date | 2009-03 |
| Est. Completion | 2016-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00842621
The ClinicalTrials.gov registry entry for NCT00842621 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 390 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 291-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (34% higher). The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sickle Cell Disease appearing as the primary indexed condition, and to 2 interventions - of which Clinical Evaluations is the first listed.
NCT00842621 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00842621 about?
NCT00842621 is a clinical study titled "Long Term Effects of Erythrocyte Lysis". In this prospective observational trial, participants with chronic hemolysis will be assessed with echocardiogram for elevated tricuspid jet velocity and other evidence of pulmonary hypertension. Participants will have laboratory studies evaluating: severity of hemolysis, splenic function, inflammat...
What is the current status of trial NCT00842621?
This trial is currently completed. The enrollment target is 390 participants. The study started on 2009-03. Estimated completion is 2016-06.
What conditions does trial NCT00842621 study?
This clinical trial studies the following conditions: Sickle Cell Disease, Hemolytic Anemia.
What interventions are being tested in trial NCT00842621?
The interventions under investigation include: Clinical Evaluations (PROCEDURE), Laboratory Studies (OTHER).
Who is sponsoring clinical trial NCT00842621?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00842621 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sickle Cell Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
RECRUITING · Phase 2
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Exercise in Child Health
RECRUITING · NA
-
Sickle Cell Children's Exercise Study (SuCCESs)
RECRUITING · NA
-
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
RECRUITING · Phase 1
-
Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.